Mostrando resultados por autor "Aimee Donnellan" en Todas las categorías

In Off the Scales, Reuters journalist Aimee Donnellan illuminates the history of the latest medical breakthrough that is poised to change the world, while bringing difficult social questions about inequality and morality to the forefront. Through original reporting and rigorous research, she forecasts the future of Ozempic and similar medications—and examines what their explosive popularity tells us about our ideals of beauty, the lengths to which people will go in order to become thin, the current state of healthcare, and the inner workings of the pharmaceutical industry.

The inside story of the race to develop Ozempic – the world's first truly effective and safe obesity drug – and its potentially revolutionary effects on public health, and our deeper culture and values. Weight loss medications like Ozempic and Wegovy were born from a breakthrough in type 2 diabetes treatment, tricking users into feeling full. But these drugs are proving so transformative that entire industries are being disrupted. The story of obesity drugs, however, goes far beyond billion dollar profits.